Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021)
Pharma-Bio Serv's (PBSV) quarterly Short term Debt came in at $1.3 million in Q2 2021, up 100.0% YoY from $643900.0 in Q2 2020, and little changed on a QoQ basis from $1.3 million in Q1 2021.
Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021) Analysis & Trends
Pharma-Bio Serv (PBSV) has 2 years of Short term Debt data on file, last reported at $1.3 million in Q2 2021.
- Quarterly Short term Debt rose 100.0% year-over-year to $1.3 million in Q2 2021, while the trailing twelve-month figure through Apr 2021 was $1.3 million (up 100.0% YoY) and the FY2020 annual result came in at $1.3 million, changed N/A from the prior year.
- Short term Debt was little changed at $1.3 million in Q2 2021, from $1.3 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.3 million in Q4 2020 to a low of $643900.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2021 | 1.29 Mn |
| Jan 31, 2021 | 1.29 Mn |
| Oct 31, 2020 | 1.29 Mn |
| Jul 31, 2020 | 965,850.00 |
| Apr 30, 2020 | 643,900.00 |